thian qin zhang, reena rahayu md zin, muaatamarulain mustangin, nur maya sabrina tizen laim, nur fa’izah ab muin, nurwahyuna rosli.  (2025).  pd-l1 expression, mismatch-repair status and tumour-infiltrating lymphocytes in triple-negative breast carcinoma.  - 10th iapmd annual scientific meeting 2025. 

 

nor haizura abd rani, nurwahyuna rosli , nur fa’izah ab muin , emilia rosniza mohammed rusli, wan syahira ellani wan ahmad kammal.  (2025).  shape-shifting spinal ependymoma: late recurrence of myxopapillary ependymoma eight years after “conventional” lumbar ependymoma resection.  - 10th iapmd annual scientific meeting 2025. 

 

nor aniza azmi, nurul uzma noor hisham, caryn chan mei hsien, nur faizah ab muin, ahmad syahmiuddin, mimi syaqirah ab razak, aminul haqim mohd nizam.  (2025).  bridging the empathy gap: psycho-oncology training and the future of patient-centered radiotherapy.  - the 25th asia-australasia conference of radiological technologists (aacrt 2025) conference.  65 - 65. 

 

izzati yussof, noraida mohamed shah, sarahfarina abd. rahim, nur fa'izah ab muin, nor asyikin mohd tahir, ernieda hatah.  (2025).  expert validation of an educational tool for breast cancer patients on endocrine therapy.  - national oncology pharmacy conference (nopc 4.0). 

 

nur fa'izah ab muin.  (2025).  angin pasang atau kanser testis.  - harian metro. 

 

hui ting eyu, nik ruzyanei nik jaafar, mohammad farris iman leong abdullah, hajar mohd salleh salimi, mohd razif mohamad yunus, fuad ismail, nur fa'izah ab muin, noor syazwani abdul aziz.  (2024).  perceived shame and stigma, and other psychosocial predictors of psychological distress among cancer patients in malaysia.  - psycho-oncology.  1 - 9. 

 

nur faizah ab muin; marniza saad; adlinda alip; muthukkumaran thiagarajan.  (2023).  the outcomes of glioblastoma multiforme:the university malaya medical centre experience 2008-2018.  - annals of oncology.  S1411. 

 

izzati yussof, nur faizah ab muin, masnizah mohd, ernieda hatah, nor asyikin mohd tahir, noraida mohamed shah.  (2023).  breast cancer prevention and treatment misinformation on twitter: an analysis of two languages.  - digital health.  1-11. 

 

izzati yussof, noraida mohamed shah, nur fa’izah ab muin, sarahfarina abd. rahim, ernieda hatah, nor asyikin mohd tahir, kavinash loganathan, murallitharan munisamy.  (2024).  challenges in obtaining and seeking information among breast cancer survivors in an asian country: a qualitative study.  - journal of cancer education.  383 - 390. 

 

nor aniza azmi, caryn chan mei hsien, nur fa'izah ab muin, ahmad syahmiuddin shamsuddin, nur afiqah mohd shukri, mimi syaqirah ab razak, aminul haqim mohd nizam.  (2024).  innovative training for future radiation therapists: designing a student-centric psychosocial and supportive cancer patient care [psosc] module in malaysia.  - journal of medical imaging and radiation sciences.  45 - 45. 

 

hui ting eyu, nik ruzyanei nik jaafar, mohammad farris iman leong abdullah, hajar mohd salleh salimi, mohd razif mohamad yunus, fuad ismail, nur fa'izah ab muin, noor syazwani abdul aziz.  (2024).  perceived shame and stigma, and other psychosocial predictors of psychological distress among cancer patients in malaysia.  - psycho-oncology.  1 - 9. 

 

nur faizah ab muin, marniza saad, adlinda alip, muthukkumaran thiagarajan.  (2024).  the outcomes of glioblastoma multiforme: the university malaya medical centre experience 2008-2018.  - journal of health and translational medicine.  49-56. 

 

izzati yussof, nur fa’izah ab muin, rick sheng tan, masnizah mohd, ernieda hatah, nor asyikin mohd tahir, noraida mohamed shah.  (2024).  breast cancer misinformation in facebook and twitter: a bilingual analysis.  - pharmacy education.  205 - 206. 

 

izzati yussof, noraida mohamed shah, nur fa’izah ab muin, sarahfarina abd. rahim, ernieda hatah, nor asyikin mohd tahir, kavinash loganathan, murallitharan munisamy.  (2024).  challenges in obtaining and seeking information among breast cancer survivors in an asian country: a qualitative study.  - journal of cancer education.  383 - 390. 

 

nur fa'izah ab muin.  (2025).  angin pasang atau kanser testis.  - harian metro. 

 

nor aniza azmi, nurul uzma noor hisham, caryn chan mei hsien, nur faizah ab muin, ahmad syahmiuddin, mimi syaqirah ab razak, aminul haqim mohd nizam.  (2025).  bridging the empathy gap: psycho-oncology training and the future of patient-centered radiotherapy.  - the 25th asia-australasia conference of radiological technologists (aacrt 2025) conference.  65 - 65. 

 

izzati yussof, noraida mohamed shah, sarahfarina abd. rahim, nur fa'izah ab muin, nor asyikin mohd tahir, ernieda hatah.  (2025).  expert validation of an educational tool for breast cancer patients on endocrine therapy.  - national oncology pharmacy conference (nopc 4.0). 

 

thian qin zhang, reena rahayu md zin, muaatamarulain mustangin, nur maya sabrina tizen laim, nur fa’izah ab muin, nurwahyuna rosli.  (2025).  pd-l1 expression, mismatch-repair status and tumour-infiltrating lymphocytes in triple-negative breast carcinoma.  - 10th iapmd annual scientific meeting 2025. 

 

nor haizura abd rani, nurwahyuna rosli , nur fa’izah ab muin , emilia rosniza mohammed rusli, wan syahira ellani wan ahmad kammal.  (2025).  shape-shifting spinal ependymoma: late recurrence of myxopapillary ependymoma eight years after “conventional” lumbar ependymoma resection.  - 10th iapmd annual scientific meeting 2025. 

 

nur fa'izah ab muin.  (2025).  angin pasang atau kanser testis.  - harian metro. 

 
A PHASE III, OPEN-LABEL, SPONSOR-BLIND, RANDOMIZED STUDY OF DATO-DXD WITH OR WITHOUT OSIMERTINIB VERSUS PLATINUM-BASED DOUBLET CHEMOTHERAPY FOR PARTICIPANTS WITH EGFR-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS... astrazeneca ab
47.8%(2024-09-26 sehingga 2028-03-25)
A PHASE III, OPEN-LABEL, SPONSOR-BLIND, RANDOMIZED STUDY OF DATO-DXD WITH OR WITHOUT OSIMERTINIB VERSUS PLATINUM-BASED DOUBLET CHEMOTHERAPY FOR PARTICIPANTS WITH EGFR-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS... parexel international (malaysia) sdn bhd.
47.8%(2024-09-26 sehingga 2028-03-25)
THE CORRELATION OF PD-L1 POSITIVITY WITH DNA MISMATCH REPAIR AND THEIR ASSOCIATIONS WITH TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER PATIENTS biomarketing services (m) sdn. bhd.
47.8%(2024-11-01 sehingga 2026-10-31)
THE CORRELATION OF PD-L1 POSITIVITY WITH DNA MISMATCH REPAIR AND THEIR ASSOCIATIONS WITH TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER PATIENTS jabatan patologi, hospital putrajaya
47.8%(2024-11-01 sehingga 2026-10-31)
A RANDOMIZED, DOUBLE-BLIND STUDY EVALUATING PHARMACOKINETIC SIMILARITY OF ABP 206 COMPARED WITH OPDIVO® (NIVOLUMAB) IN RESECTED STAGE III OR STAGE IV MELANOMA SUBJECTS IN THE ADJUVANT SETTING parexel international (malaysia) sdn bhd
47.8%(2023-06-22 sehingga 2026-08-21)
ELACESTRANT VERSUS STANDARD ENDOCRINE THERAPY INWOMEN AND MEN WITH NODE-POSITIVE, ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE, EARLY BREAST CANCER WITHHIGH RISK OF RECURRENCE—A GLOBAL, MULTICENTER, RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (ELEGANT) stemline therapeutics, inc.
47.8%(2025-01-09 sehingga 2033-01-08)